Human Leukocyte Antigen (HLA) Typing for Transplant Market worth US$1.4 billion by 2030 with 6.0% CAGR
DELRAY BEACH, Fla., May 22, 2025 /PRNewswire/ -- The global Human Leukocyte Antigen (HLA) Typing for Transplant, valued at US$1.0 billion in 2024, is forecasted to grow at a robust CAGR of 6.0 %, reaching US$1.1 billion in 2025 and an impressive US$1.4 billion by 2030. The escalating demand for organ transplants, which is a prime market driver, is closely associated with lifestyle and occupational risk factors. Sedentary behaviour, poor dietary habits, obesity, diabetes mellitus, and hypertension significantly contribute to the prevalence of chronic kidney and liver diseases. The detrimental effects of alcohol consumption and tobacco use lead to liver cirrhosis and exacerbate COPD, thereby increasing the necessity for liver and lung transplants. Furthermore, occupational exposure to industrial toxins, particularly seen in mining and manufacturing sectors, can result in significant hepatic and pulmonary damage. An aging workforce, coupled with an uptick in cardiovascular morbidity, further intensifies the demand for heart transplants. These trends highlight the critical role of HLA typing in facilitating donor-recipient compatibility, which is essential for improving transplant success rates.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=96374742
Browse in-depth TOC on "HLA Typing for Transplant Market"
250 - Tables50 - Figures350 - Pages
By Based on product & service, the HLA typing market for transplants is categorized into three segments: software & services, reagents &consumables, and instruments. In 2024, the reagents & consumables segment led in global market share; this growing prominence is primarily driven by a rising demand for precise and rapid identification of HLA alleles, which play a crucial role in transplantation procedures. The ability to quickly and accurately determine HLA compatibility ensures successful organ transplants. It minimizes the risk of rejection, which, in turn, highlights the critical need for advanced reagents and consumables. As healthcare providers increasingly prioritize efficient transplantation processes and improved patient outcomes, this segment is expected to grow substantially, fueled by ongoing innovations and advancements in molecular biology techniques. Such developments will further enhance the effectiveness and reliability of HLA typing, making this an exciting area for investment and development in the coming years.
By Based on technology, HLA typing for transplantation is categorized into two main segments: molecular assays and non-molecular assays. The molecular-based assays segment commands a significant market share, primarily due to the extensive implementation of advanced molecular technologies, including next-generation sequencing (NGS) and polymerase chain reaction (PCR) methodologies, in transplant facilities and healthcare institutions. These molecular techniques offer superior resolution in HLA typing compared to conventional serological methods, enhancing the accuracy and reliability of donor-recipient matching.
By end user, the HLA typing for the transplant market is categorized into independent reference laboratories, hospitals & transplant centers, and research laboratories & academic institutes. In 2024, independent reference laboratories dominated the HLA typing segment of the transplant market due to their ability to handle high sample throughput effectively and specialized expertise in conducting intricate HLA tests and accurately interpreting the results. Their commitment to delivering superior quality HLA typing services further solidified their position in this sector.
By geography, in 2022, North America held the predominant share of the HLA typing market for transplant, followed closely by Europe. The Asia Pacific region is expected to experience the most rapid growth in this sector throughout the forecast period. North America's supremacy in the HLA typing market can be attributed to several factors: a significant increase in organ transplantation procedures, a robust presence of companies providing transplant diagnostic products—including HLA typing services—and an upsurge in collaborative research efforts aimed at identifying novel HLA genes and elucidating their implications in organ transplantation.
Request Sample Pages : https://www.marketsandmarkets.com/requestsampleNew.asp?id=96374742
Thermo Fisher Scientific (US), Illumina, Inc. (US), QIAGEN (Germany), CareDx, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (US), Immucor, Inc. (US), Werfen (US), TBG Biotechnology Corporation (Taiwan), Fujirebio (Japan), Omixon Inc. (US), GenDX (Netherlands), BAG Diagnostics GmbH (Germany), Creative Biolabs (US), and PacBio (US)
Thermo Fisher Scientific (US):
Thermo Fisher Scientific is a preeminent entity in the domain of HLA typing for transplant applications, driven by strategic investments and a robust growth trajectory in this sector. The company provides extensive offerings encompassing PCR-based assays, advanced sequencing technologies, and comprehensive software solutions tailored for HLA typing. This diverse product portfolio meets the varied requirements of transplant centers and laboratories, ensuring optimized workflows and enhanced accuracy. To maintain its competitive edge, Thermo Fisher prioritizes R&D, continually advancing its HLA typing technologies; this unwavering commitment to innovation enhances its product capabilities and positions it at the forefront of the industry, delivering cutting-edge solutions that address the evolving needs of the transplant immunology landscape.
QIAGEN (Germany):
QIAGEN provides extensive products and solutions tailored for HLA typing, encompassing PCR-based assays, next-generation sequencing (NGS) platforms, and associated reagents. This robust product portfolio positions QIAGEN to effectively meet the varied demands of transplant centers and clinical laboratories. QIAGEN's NGS-based offerings, such as the QIAseq HLA Typing Panel, invest significantly in developing cutting-edge technologies for HLA typing and delivering high-resolution and precise HLA typing results. These advancements enhance transplant matching efficacy and overall patient outcomes. With a strong global market presence, QIAGEN leverages a comprehensive network of distribution channels and strategic partnerships across multiple regions, enabling it to serve a diverse clientele of transplant centers and laboratories worldwide. Strategic acquisitions and collaborations have fortified QIAGEN's standing in the market. Notably, the acquisition of N-of-One, Inc. has expanded its capabilities in precision medicine and clinical decision support, with significant implications for transplantation applications. Additionally, QIAGEN offers customizable products that accommodate the specific requirements of individual laboratories and transplant centers, providing flexibility that appeals to a broad spectrum of customers. The company frequently collaborates with research institutions and organizations engaged in transplantation research, further reinforcing its commitment to advancing the field.
Illumina, Inc. (US):
Illumina, Inc. is a leading entity in genomics, particularly noted for its advancements in HLA typing for transplantation. Its DNA sequencing platforms, including the HiSeq and NovaSeq systems, are implemented in HLA typing protocols due to their high throughput, precision, and scalability, which are crucial for extensive HLA typing endeavors. As a pioneer in next-generation sequencing (NGS) technology, Illumina has significantly transformed HLA typing methodologies, enabling high-resolution typing that enhances donor-recipient matching and, subsequently, transplant success rates. The company has engaged in strategic collaborations with various organizations within transplantation research and diagnostics, fostering innovation and broadening the scope of its sequencing technologies. Continuous R&D investments have been a hallmark of Illumina's operation, focusing on creating specialized assays and workflows tailored specifically for HLA typing and transplantation research applications. Illumina's sequencing technologies are employed in research and clinical laboratories globally, allowing the company to support transplant centers, hospitals, and research institutions worldwide, which has propelled its expansion in the HLA typing sector. Furthermore, Illumina provides an array of bioinformatics tools and software that help analyze and interpret HLA data, extracting meaningful insights from the extensive datasets generated during HLA typing procedures.
For more information, Inquire Now!
Related Reports:
PCR Technologies Market
Digital PCR (dPCR) and Real-time PCR (qPCR) Market
Next-Generation Sequencing Market
Biomarkers Market
Bioinformatics Market
Get access to the latest updates on HLA Typing for Transplant Companies and HLA Typing for Transplant Market Size
About MarketsandMarkets™:
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.
Contact:Mr. Rohan SalgarkarMarketsandMarkets™ INC.1615 South Congress Ave.Suite 103, Delray Beach, FL 33445USA: +1-888-600-6441Email: sales@marketsandmarkets.comVisit Our Website: https://www.marketsandmarkets.com/
Logo: https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/human-leukocyte-antigen-hla-typing-for-transplant-market-worth-us1-4-billion-by-2030-with-6-0-cagr--marketsandmarkets-302462872.html
SOURCE MarketsandMarkets
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
Zero Gravity Lifts off on Documentary Showcase
LOS ANGELES, June 6, 2025 /PRNewswire/ -- Scientology Network's DOCUMENTARY SHOWCASE, the weekly series providing a platform for Independent filmmakers to air films on important social, cultural and environmental issues, presents the celestial documentary Zero Gravity on June 6, 2025. DOCUMENTARY SHOWCASE airs Fridays at 8 p.m. ET/PT on Scientology Network. In Zero Gravity, middle school students from San Jose, California, enter a nationwide NASA tournament to code satellites aboard the International Space Station (ISS). Led by an inspiring first-time coach, the team rises from budding digital dreamers to ultimately represent California in the ISS finals tournament—where astronauts execute the young coders' algorithms in orbit, 250 miles above Earth. Directed by Thomas Verrette, the film follows the kids' transformation and serves as a powerful reminder: the future begins with those bold enough to imagine it. An official selection at over 70 film festivals—including DOC NYC, Cinequest and the Cleveland International Film Festival—Zero Gravity has won 18 documentary awards from Audience Choice to Best Editing. Endorsed by scientists and educators, the film has reached more than 10,000 students nationwide through classroom and community screenings. ABOUT THOMAS VERRETTE Thomas Verrette is an award-winning director, producer and editor. A more than 15-year veteran of the film industry, Verrette is a former FOX and Disney creative and post-production executive. He is most known for producing the 20-episode World Cup docu-series Phenoms for FOX Sports. Verrette began his career upon graduating from the Savannah College of Art and Design. Zero Gravity is his first feature documentary as a director. ABOUT DOCUMENTARY SHOWCASE Fundamental to Scientology is a humanitarian mission that extends to some 200 nations with programs for human rights, human decency, literacy, morality, drug prevention and disaster relief. For this reason, the Scientology Network provides a platform for Independent filmmakers who embrace a vision of building a better world. DOCUMENTARY SHOWCASE debuts films weekly from award-winning Independent filmmakers whose goal is to improve society by raising awareness of social, cultural and environmental issues. For more information, visit Scientology Network debuted on March 12, 2018, launched by David Miscavige, ecclesiastical leader of the Scientology religion. Since then, Scientology Network has been viewed in over 240 countries and territories worldwide in 17 languages. Satisfying the curiosity of people about Scientology, the network takes viewers across six continents, spotlighting the everyday lives of Scientologists, showing the Church as a global organization and presenting its Social Betterment programs that have touched the lives of millions worldwide. The network also showcases documentaries by Independent filmmakers who represent a cross section of cultures and faiths, but share a common purpose of uplifting communities. Scientology Network's innovative content has been recognized with more than 125 industry awards, including Tellys, Communitas and Hermes Creative Awards. Broadcast from Scientology Media Productions, the Church's global media center in Los Angeles, Scientology Network is available on DIRECTV Channel 320, DIRECTV STREAM and AT&T U-verse and can be streamed at on mobile apps and via the Roku, Amazon Fire and Apple TV platforms. View original content to download multimedia: SOURCE Church of Scientology International
Yahoo
3 hours ago
- Yahoo
46 State Medical Associations Urge Senate to Reject Medicaid Cuts in H.R. 1
The House Budget Reconciliation bill will cause at least 7.8 million Medicaid enrollees to lose their health care coverage. SACRAMENTO, Calif., June 6, 2025 /PRNewswire/ -- Just days ahead of an expected Senate vote on H.R. 1, 46 state medical associations, as part of Physicians for Medicaid have sent a letter to the United States Senate urging them to reject the dangerous cuts to Medicaid proposed in H.R. 1 that will cause millions of patients to lose coverage and even more to lose access to care - children, pregnant women, seniors, veterans, the disabled and working families. Statewide hospital associations have also weighed in, as proposed cuts impact all providers, including physicians and hospitals. The bill, which includes $200 billion in cuts to the existing and longstanding provider taxes, would have a catastrophic effect on state budgets and the country's entire health care delivery system and would impact 49 state Medicaid programs. Provider taxes have been authorized under federal law, approved by both Republican and Democratic administrations, and affirmed by state legislatures in 49 states for decades. They are a legitimate financing mechanism used by states in partnership with the federal government to fund essential health services and have kept rural hospitals, maternity wards, nursing homes, and physician practices open. The bill also imposes damaging changes to federal student loan programs making it harder for students to pursue medical careers at a time of critical physician shortages. We urge the Senate to pursue more balanced solutions that expand the physician workforce and preserve Medicaid for our patients. "If these provider tax cuts are enacted, it will create significant gaps in State budgets, forcing states to raise taxes, or reduce benefits, coverage, and provider payments. These reductions will lead to even more crowding of emergency departments and as the uncompensated care burdens grow from patients losing coverage, many rural hospitals, nursing homes, and community physician practices will be forced to close to all patients," the letter says. There are three main provisions in H.R. 1 (as passed by the House of Representatives on May 22, 2025) that will drastically limit or eliminate existing provider taxes nationwide. These provisions below apply to all provider taxes, including hospitals, nursing homes, managed care organizations, and other provider categories. Moratorium on New or Increased Provider Taxes (SEC. 44132) – Under the provisions of H.R. 1, none of these taxes could be increased after the passage and enactment of the law nor can any new taxes be adopted by the state Legislatures (there are 19 categories of provider taxes). This provision would freeze taxes and not keep pace with increasing health care costs over time. It is also not equitable between states. Revising Payments for Certain State Directed Payments (SEC. 44133) – Once a provider tax is established, state Medicaid programs can fund supplemental or enhanced payments to providers using a variety of rate methodologies. Under H.R. 1, any future directed payments would be limited to the Medicare payment rate. Medicare physician payment rates are already 33% behind the costs to provide health care. These rates will not keep pace for public hospitals and physician specialists that care for the sickest patients nationwide. Requirements Regarding Waiver of Uniform Tax Requirement for Medicaid Provider Tax (SEC. 44134) – The language in H.R. 1 requires provider taxes in multiple states to uniformly tax hospitals, nursing homes, and managed care organizations within each category of provider tax. The uniformity requirement will be extremely difficult for most states to meet and therefore, it eliminates multiple provider taxes in many states. The HHS Secretary has discretion to allow for a transition period, which is not something upon which states can rely. "These provisions will destabilize state health systems, reduce access to care, and worsen physician shortages. Instead, we encourage you to protect Medicaid – a proven, cost-effective safety net that serves 80 million vulnerable Americans," the letter concluded. View original content to download multimedia: SOURCE California Medical Association; Physicians for Medicaid Sign in to access your portfolio
Yahoo
4 hours ago
- Yahoo
NEDHSA to host JiggAerobics event
MONROE, La., June 6, 2025 /PRNewswire/ -- Northeast Delta Human Services Authority (NEDHSA) is hosting its seventh JiggAerobics event beginning at 6 p.m. June 12 at Monroe Downtown River Market, 316 S. Grand St. NEDHSA Executive Director Dr. Monteic A. Sizer said the event provides a fun and upbeat activity for individuals of all ages and fitness levels. "Fitness plays an important role in mental health and, when coupled with proper exercise, is a strong predictor of positive health outcomes," Dr. Sizer said. "By hosting events such as JiggAerobics, we are providing an opportunity for citizens of northeast Louisiana to engage in healthy activities and learn about the interconnectedness of their mental and physical health." The event is part of NEDHSA's #getfitHSA initiative, which supports NEDHSA's integrated care model by increasing access to healthy activities and informing communities about the importance of staying fit and active. Data shows that heart disease, obesity and other physical illnesses are correlated with various forms of trauma, stress and mental illness, Dr. Sizer said. The event will be led by JiggAerobics founder LaDonte Lotts, also known as "Mr. Get Right." The dance-based fitness program fuses jigging -- an energetic Louisiana dance style -- with Lotts' dance moves and numerous plyometric exercises. NEDHSA consistently works to understand the unique health care needs of the citizens of Northeast Louisiana. "Once we understand the needs and wishes of the people, we actively put programs and services in place to help meet people where they are," Dr. Sizer said. Register for free tickets at View original content to download multimedia: SOURCE Northeast Delta Human Services Authority Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
